Connect with us
Wise usd campaign
ADVERTISEMENT

Press Release

HoneyNaps actively supplies "AI solutions" to U.S. medical institutions

Published

on

  • Rapid commercialization and delivery to the U.S. after FDA approval
  • Aiming to achieve a 10% market share within three years
  • Aggressive sales and expansion of distribution network through U.S. subsidiaries

BOSTON, Oct. 7, 2024 /PRNewswire/ — HoneyNaps announced on September 9th that it has officially begun exporting by delivering its artificial intelligence sleep disorder diagnostic software "SOMNUM" to two medical institutions in the U.S.

eXplainable A.I, SOMNUM
eXplainable A.I, SOMNUM

The SOMNUM solution supplied to the U.S. is the third globally to receive approval from the U.S. Food and Drug Administration(FDA) in 2023. It is not just a system for interpreting biometric signal images, but a deep learning-based AI interpretation system capable of real-time analysis of multi-channel/temporal and large-scale biometric signals, developed using the world’s first explainable medical AI (XAI, eXplainable AI) technology.

The SOMNUM solution will be introduced into research on sleep health for seniors and the verification of sleep improvement programs. HoneyNaps has signed a licensing agreement based on annual usage fees for the software.

HoneyNaps is currently strengthening its B2B business with major companies in South Korea while simultaneously focusing on local sales through its U.S. subsidiary in Boston and its West Coast dealer channels, expecting continuous growth in export volume.

A HoneyNaps representative said, "The U.S. is the largest sleep medicine market in the world and still holds significant growth potential. As we officially enter the U.S. market, we will solidify our business strategy to achieve a 10% market share within three years."

For further information, please contact:
HoneyNaps USA, Inc.
Christine Kwon / Managing Director
Email: sleep@honeynaps.com
Address: #517, 5th Fl., 361 Newbury Street, Boston, MA 02115
Website: www.honeynaps.com

 

 

Source : HoneyNaps actively supplies "AI solutions" to U.S. medical institutions

The information provided in this article was created by Cision PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ThailandChina.
Continue Reading

Corporate

Will you still have an office in the post Covid-19 world?

Businesses waste vast resources paying leases for real estate they simply don’t need. Flexible working spaces are a vital way of ensuring that no longer happens.

Published

on

HONG KONG – (ACN Newswire) – While the pandemic has led many to believe remote work will become the norm, concerns about lagging creativity and loneliness show that there is still a role for the office in a post Covid-19 world, according to The Executive Centre (TEC).

(more…)
Continue Reading

Markets

Tiger Trade Launches SGX Trading, Meeting Demand from Asian Investors

Access to the Singapore Exchange (SGX) adds to Tiger Brokers’ current menu of stock exchanges, such as the New York Stock Exchange (NYSE) and the Nasdaq Stock Market (NASDAQ), the world’s two largest stock exchanges, as well as the Hong Kong Stock Exchange (HKEX).

Published

on

SINGAPORE (ACN Newswire) – Tiger Trade, a one-stop mobile and online trading application by Tiger Brokers, has launched access to the Singapore Exchange (SGX).

(more…)
Continue Reading

Health

APRIL International Care opens up TeleHEALTH service to address Coronavirus worries

The TeleHEALTH service means policyholders do not have to leave their home or workplace to “see” a doctor, with a consultation happening directly over the phone

Published

on

By

Hong Kong February 10, 2020 – APRIL International Care has opened up its TeleHEALTH service to all individual and group clients across its Asian region to provide support for clients during the current Coronavirus outbreak.

(more…)
Continue Reading